Learning Objectives     

    At the conclusion of this activity, participants will be able to:

  1. Summarize evidence for first line systemic therapies for thymic carcinoma
  2. Review natural history and workup of thymic carcinoma
Session date: 
01/29/2026 - 8:00am to 9:00am CST
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Please login or create an account to proceed.
Speaker Name: 
Hemanth Potluri, MD, PhD